Abstract

Pharmaceutical Patent AnalystVol. 2, No. 2 Hot TopicNavigating the maze of IP/regulatory rights in the EU: the complex interaction between the SPC and Pediatric RegulationsMaria Isabel Manley & Marina VickersMaria Isabel Manley* Author for correspondenceBristows LLP, 100 Victoria Embankment, London EC4Y 0DH, UK. Search for more papers by this authorEmail the corresponding author at marie.manley@bristows.com & Marina VickersBristows LLP, 100 Victoria Embankment, London EC4Y 0DH, UKSearch for more papers by this authorPublished Online:26 Feb 2013https://doi.org/10.4155/ppa.13.7AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleReferences1 Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products.Google Scholar2 Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20.EC, Directive 2001/83/EC and Regulation (EC) No 726/2004.Google Scholar3 Dr Reddy’s Laboratories (UK) Ltd and Dr Reddy’s Laboratories Ltd v. Warner-Lambert Company LLC, EWHC 3715 (Pat) (2012).Google Scholar4 Council Regulation (EEC) No 1768/92 concerning the creation of a supplementary protection certificate for medicinal Products (now repealed and replaced by Regulation (EC) No 469/2009).Google Scholar5 Merck Sharp and Dohme Corp (previously Merck and Co) v. Deutsches Patent- und Markenamt, Case C-125/10 (2011).Google Scholar6 EI Du Pont de Nemours & Co v. UK Intellectual Property Office, EWCA Civ 966 (2009).Google ScholarFiguresReferencesRelatedDetails Vol. 2, No. 2 Follow us on social media for the latest updates Metrics Downloaded 90 times History Published online 26 February 2013 Published in print March 2013 Information© Future Science LtdFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call